PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11012835-5	2000	bFGF was also the most active at 3-DIV, and IGF-I at 8-DIV, in counteracting SD-induced cell death, whereas EGF was the most potent in increasing [3H]thymidine incorporation.	Thymidine	150-159	fibroblast growth factor 2	Mus musculus	0-4	
15830105-10	2005	VEGF, bFGF and SCF increased [(3)H]-thymidine incorporation of bone marrow endothelial cells.	Thymidine	36-45	fibroblast growth factor 2	Mus musculus	6-10	
11154844-4	2000	Pre-treatment of hypothalamic astrocytes with an inactive ("priming") dose of bFGF for 12 h powerfully increased astroglia proliferative response to IGF-I (10 ng/ml), EGF (10 g/ml) and insulin (10 microg/ml), inducing a 65-100% increase in the [3H]thymidine incorporation compared to untreated cultures.	Thymidine	248-257	fibroblast growth factor 2	Mus musculus	78-82	
9845352-1	1998	Basic fibroblast growth factor (bFGF) stimulated [3H]thymidine incorporation at all stages of development, although the magnitude of this effect was the greatest in cells derived from pregnant mice.	Thymidine	53-62	fibroblast growth factor 2	Mus musculus	0-30	
9845352-1	1998	Basic fibroblast growth factor (bFGF) stimulated [3H]thymidine incorporation at all stages of development, although the magnitude of this effect was the greatest in cells derived from pregnant mice.	Thymidine	53-62	fibroblast growth factor 2	Mus musculus	32-36	
9344845-4	1997	[3H]thymidine uptake in HBL100 cells and Balbc/3T3 cells by exogenous FGF2 was inhibited by CMDB7.	Thymidine	4-13	fibroblast growth factor 2	Mus musculus	70-74	
9160859-5	1997	Measurement of [3H]thymidine incorporation into quiescent cells stimulated with increasing concentrations of serum, showed increased DNA synthesis in cell lines expressing any bFGF isoform when compared to non-transgenic control cells, and a further increase in DNA synthesis in cells expressing the nuclear targeted isoforms (24, 22, and 21 kDa) over the 18 kDa bFGF expressing cell line at any concentration of serum.	Thymidine	19-28	fibroblast growth factor 2	Mus musculus	176-180	
9160859-5	1997	Measurement of [3H]thymidine incorporation into quiescent cells stimulated with increasing concentrations of serum, showed increased DNA synthesis in cell lines expressing any bFGF isoform when compared to non-transgenic control cells, and a further increase in DNA synthesis in cells expressing the nuclear targeted isoforms (24, 22, and 21 kDa) over the 18 kDa bFGF expressing cell line at any concentration of serum.	Thymidine	19-28	fibroblast growth factor 2	Mus musculus	363-367	
7733666-3	1995	The addition of bFGF (0.1 to 1.0 ng/ml) to serum-deprived SHE cells stimulated a six- to sevenfold increase in the incorporation of thymidine into DNA.	Thymidine	132-141	fibroblast growth factor 2	Mus musculus	16-20	
7852327-5	1995	In addition, using a radioreceptor assay, we have shown that phosphorothioate homopolymers of cytidine and thymidine blocked binding of not only 125I-bFGF, but also of 125I-PDGF to NIH 3T3 cells, whereas phosphodiester oligodeoxynucleotides were ineffective.	Thymidine	107-116	fibroblast growth factor 2	Mus musculus	150-154	
7852327-9	1995	We have also demonstrated that phosphorothioate homopolymers of cytidine and thymidine release bFGF bound to low affinity receptors in extracellular matrix (ECM).	Thymidine	77-86	fibroblast growth factor 2	Mus musculus	95-99	
8089657-13	1994	Basic fibroblast growth factor (bFGF) is an even more potent mitogen, promoting thymidine incorporation, cell division, and a net increase in cell number equal to that in serum.	Thymidine	80-89	fibroblast growth factor 2	Mus musculus	0-30	
8089657-13	1994	Basic fibroblast growth factor (bFGF) is an even more potent mitogen, promoting thymidine incorporation, cell division, and a net increase in cell number equal to that in serum.	Thymidine	80-89	fibroblast growth factor 2	Mus musculus	32-36	
1468448-7	1992	3T3 [3H]thymidine incorporation assays indicated that the beta-D xyloside-induced reduction of matrix-associated bFGF coincided with a significant increase in bFGF activity in the conditioned media.	Thymidine	8-17	fibroblast growth factor 2	Mus musculus	113-117	
1392061-6	1992	The bFGF concentrations determined by this colorimetric assay correlated well with those determined by both the [3H]-thymidine incorporation assay using BALB/c 3T3 fibroblast cells (r = 0.998) and the cell number count assay (r = 0.996).	Thymidine	117-126	fibroblast growth factor 2	Mus musculus	4-8	
25356638-9	2015	Consistently, IGF-1 promoted the G2/M progression of thymidine-treated mSSCs, which were arrested at G1/S boundary synchronously; while GDNF and/or FGF2 stimulated their entry into the S phase.	Thymidine	53-62	fibroblast growth factor 2	Mus musculus	148-152	
17848635-5	2007	FGF2 stimulated pituitary cellular proliferation (MTS assay and [(3)H]thymidine incorporation), with no differences between genotypes.	Thymidine	70-79	fibroblast growth factor 2	Mus musculus	0-4	
8440329-8	1993	CDGF together with small concentrations of bFGF (3.5 pM), higher concentrations of PDGF (300 pM), or IGF-I (1 nM) increased synergistically thymidine incorporation in the 2-h pulse, exceeding in the case of PDGF and bFGF the values obtained with 10% serum.	Thymidine	140-149	fibroblast growth factor 2	Mus musculus	43-47